Houlihan Lokey, Inc.
HLI · NYSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.67 | 3.37 | -0.54 | 0.31 |
| FCF Yield | 7.62% | 3.17% | 1.54% | 12.76% |
| EV / EBITDA | 16.87 | 18.57 | 11.96 | 7.66 |
| Quality | ||||
| ROIC | 13.76% | 11.34% | 13.09% | 25.91% |
| Gross Margin | 38.50% | 38.50% | 38.50% | 37.94% |
| Cash Conversion Ratio | 2.12 | 1.17 | 0.54 | 1.68 |
| Growth | ||||
| Revenue 3-Year CAGR | 9.71% | -5.52% | 5.86% | 25.10% |
| Free Cash Flow Growth | 209.07% | 205.96% | -88.25% | 28.68% |
| Safety | ||||
| Net Debt / EBITDA | -0.89 | -0.72 | -0.78 | -0.96 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 29.32 | 45.54 | 26.29 | 7.30 |